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ABSTRACT
Placental mesenchymal dysplasia (PMD) is a rare placental abnormality. We report a case 
of PMD associated with intrauterine growth restriction (IUGR), which was diagnosed by 
an ultrasound scan during the second trimester of pregnancy. A 36-year-old primiparous 
woman with signs of placental chorioangioma was referred to our hospital at the 23th 
gestational week. An ultrasonography revealed a small-for-gestational-age fetus with 
a large multicystic placenta. A serial Doppler sonographic assessment of umbilical and 
uterine artery blood flow showed a compromised fetus. A female, small-for-gestational-age 
baby was delivered by c-section at 28 weeks, and PMD was histopathologically confirmed.
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Placental mesenchymal dysplasia (PMD) is a rare type of placental lesion, often 
associated with severe intrauterine growth restriction (IUGR) and fetal death. Our 
objective was to report a case of PMD involving a serial Doppler velocimetry study 
followed by a live birth. A 36-year-old primiparous woman with chronic hypertension 
and signs of placental chorioangioma confirmed by imaging was referred to our 
hospital at the 23th gestational week. An ultrasonography revealed a large multicystic 
placenta and fetal growth at the 10th percentile. Color Doppler imaging showed 
an absence of end-diastolic frequency in the umbilical artery (UA). The differential 
diagnosis included either molar pregnancy or PMD (Figure 1). Fetal karyotype was 
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Figure 1: Ultrasound at 26 weeks of gestation. The image shows placental mesechymal 
dysplasia, with hypo echoic areas that can resemble a molar pregnancy.
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performed in amniotic fluid, and the result was 46,XX. 
Fetal echocardiography revealed right ventricular 
hypertrophy. A fetal ultrasound examination at 27 weeks 
of pregnancy revealed oligohydramnios, multicystic 
placenta, and fetal growth below the 5th percentile. 
Doppler imaging showed an absennce of end-diastolic 
frequency in the UA and a middle cerebral artery (MCA) 
resistance index (RI) of 0.7. At 27 weeks and 6 days of 
pregnancy, imaging showed a fetal growth  below the 5th 
percentile, an MCA IR of 0.95, and an UA IR of 1.53 with 
absent end-diastolic frequency, uterine arteries with early 
diastolic notching, and a reduction in the A component of 
the flow velocity waveform in the ductus venosus (Figure 2), 
indicating time of delivery. The patient was administered 
two doses of betamethasone and magnesium sulfate for 
neuroprotection. A 655 g female baby was delivered via 
c-section at 28 weeks of pregnancy with Apgar scores 
of 6 and 8, at 1 and 5 minutes, respectively, and was 
immediately transferred to the neonatal intensive care unit. 
The graph with the estimated fetal body weight curve is 
shown in Figure 3 and revealed a small-for-gestational-age 
newborn. A gross examination showed that the placenta 
was monochorionic and monoamniotic, weighed 255 g, 
and had velamentous umbilical cord insertion. Vesicles 
were found in 80% of the parenchymas, which were 
hemorrhagic and had lacerations (Figure 4). Microscopic 
examination showed large hydropic stem villi and vessels 
with thick walls lacking trophoblast proliferation. PMD was 
histopathologically confirmed (Figure 5).
PMD was first described in 1991 by Moscoso. It is a rare 
benign condition of placentomegaly and abnormal chorionic 
villi, often clinically mistaken for a partial hydatidiform 
mole, which is clinicopathologically distinct and has a high 
incidence of IUGR and fetal death1,2. The exact incidence 
of PMD is unknown, but it is generally assumed to be 
about 0.02% and is associated with Beckwith-Wiedemann 
syndrome (macrosomia, exomphalos, macroglossia, 
omphalocele, craniofacial features, and ear anomalies) in 
about 20% of cases. A high rate of IUGR is observed in about 
50% of cases3-6. Sonographs show enlarged placentas 
with multicystic anechoic regions and widely distributed, 
large, edematous villi, which can be seen under gross 
examination7-9. Microscopically, these vesicles correspond to 
dilated stem vessels, with thickened vasculature surrounded 
by normal villi1. These placental histopathological 
characteristics seem to be responsible for changes in the 
Doppler-velocimetric waveforms and may result in IUGR 
and fetal death. This is explained by a potentially chronic 
hypoxia secondary to obstructive fetal vascular thrombosis 
and decreased maternal-fetal gas exchange due to an 
insufficient amount of normal chorionic villi and shunting 
of blood from the exchange surface in the dysplastic villi5. 
Doppler evaluation may play a role in these cases10.
PMD should be included in the differential diagnosis for 
ultrasound findings that reveal a normal-looking fetus with 
cystic lesions of the placenta because management and 
outcomes differ. PMD is probably under-diagnosed and 
under-reported due to sonologists, pathologists and other 
healthcare providers being unfamiliar with this obstetric 
condition. Additionally, patients should be advised of the 
increased risk of preeclampsia, fetal demise, and maternal 
morbidity. Prenatal care involving Doppler velocimetry 
studies seems to be essential for increased fetal survival 
in cases of placental abnormalities. Further research is 
necessary on the true incidence of complications and on 
the types of complications associated with PMD.
Figure 3: Graph of estimated fetal body weight (case in red).
Figure 2: Doppler ultrasound findings.
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Figure 5: Central vessels with fibromuscular sclerosis increased 
in villous stromal fibrosis with degeneration (HE, 50 X).
Figure 4: Macroscopic aspect of the placenta.
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